Skip to main content
. 2015 Sep 7;2015:197241. doi: 10.1155/2015/197241

Table 2.

Cross-resistance of doxorubicin-resistant cells to other chemotherapeutic agents.

Agents IC50 P value IC50 P value
Jurkat Doxorubicin-resistant Jurkat H9 Doxorubicin-resistant H9
Cisplatin (uM) 6.2 ± 0.3 9.0 ± 0.4 0.0039 5.7 ± 0.3 8.5 ± 0.5 0.0067
Cyclophosphamide (mM) 3.3 ± 0.2 4.8 ± 0.2 0.0056 2.4 ± 0.2 3.9 ± 0.3 0.0106